tldrdailynews.com logo

Metsera's Monthly Weight Loss Drug Shows Promising Early Results

1 min read
Source: statnews.com
Metsera's Monthly Weight Loss Drug Shows Promising Early Results
Photo: statnews.com
TL;DR

Metsera's experimental drug targeting the amylin hormone showed promising results in early clinical trials, indicating potential for longer-lasting weight loss effects compared to existing weekly injections, highlighting a significant development in obesity treatment.

Topics:businessbiotech#amylin#biotech#clinical-trial#drug-trial#metsera#obesity
Share this article
  1. Metsera’s drug shows potential in early clinical trial  statnews.com
  2. Weight-loss newbie Metsera says once-monthly amylin matches GLP-1 efficacy  FirstWord Pharma
  3. Obesity Startup Metsera Shares Rise on Early-Stage Trial Results  Bloomberg.com
  4. Metsera Shares Rise as Monthly Weight Loss Injection Shaves Over 8% Body Weight at 36 Weeks  BioSpace
  5. Obesity Newcomer Metsera Enters The Ring With A Punch — And A Big Stock Jump  Investor's Business Daily

Want the full story? Read the original reporting

Read on statnews.com